Cross-talk between alpha(1B)-adrenergic receptor (alpha(1B)AR) and interleukin-6 (IL-6) signaling pathways. Activation of alpha(1b)AR inhibits il-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism.
about
High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes.The α1-adrenergic receptors: diversity of signaling networks and regulationSTAT3 signaling: anticancer strategies and challenges.Crosstalk between signaling pathways of adrenoreceptors and signal transducers and activators of transcription 3 (STAT3) in heart.Advances in the design and synthesis of prazosin derivatives over the last ten years.Mercury alters endotoxin-induced inflammatory cytokine expression in liver: differential roles of p38 and extracellular signal-regulated mitogen-activated protein kinases.Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-depCross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.Expression of interferon alfa signaling components in human alcoholic liver disease.SP-A2 contributes to miRNA-mediated sex differences in response to oxidative stress: pro-inflammatory, anti-apoptotic, and anti-oxidant pathways are involved.
P2860
Q30408290-AC0E444F-47F0-444A-A10E-2F68C5A96D17Q31864260-5E3D095A-F529-42F1-A83A-859E842E9C96Q33919595-9362F469-4FEA-452D-AB00-8FC56DD41086Q34476637-95E56534-AB4E-4AF7-8A2B-55C5935FD80AQ34715455-29DAD02D-65A5-4532-9A7A-B5F4B351AB77Q36714559-33B526D0-FDBE-458F-8146-62BA02F88894Q36827500-4B371BFF-B47C-4905-AFB7-440FB9D3ACCEQ40440162-03F1D23C-1453-4150-80B4-21D6522C6C4FQ40865178-F53D3EED-6FD9-40C8-A9DA-B1323A5A77F3Q42004459-3891A944-655D-4DBC-B15F-C69F9E38E3BCQ42140949-FED971ED-53BA-4F26-BCD0-0A0A9A3CA049Q43875858-B31C4127-BA4A-45E9-8AFE-6C32336FDC54Q46248517-D2E43098-699F-463D-A0BA-A96A6C656289
P2860
Cross-talk between alpha(1B)-adrenergic receptor (alpha(1B)AR) and interleukin-6 (IL-6) signaling pathways. Activation of alpha(1b)AR inhibits il-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Cross-talk between alpha
@nl
Cross-talk between alpha(1B)-a ...... in kinase-dependent mechanism.
@en
type
label
Cross-talk between alpha
@nl
Cross-talk between alpha(1B)-a ...... in kinase-dependent mechanism.
@en
prefLabel
Cross-talk between alpha
@nl
Cross-talk between alpha(1B)-a ...... in kinase-dependent mechanism.
@en
P2860
P356
P1476
Cross-talk between alpha(1B)-a ...... in kinase-dependent mechanism.
@en
P2093
P2860
P304
35492-35498
P356
10.1074/JBC.274.50.35492
P407
P577
1999-12-01T00:00:00Z